SIBN SI-BONE Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SIBN

Price (delayed)

$14.88

Market cap

$659.92M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.39

Enterprise value

$669.33M

?
Relative Growth: Rel. Growth: 63
Relative Strength: Rel. Strength: 22
Relative Valuation: Rel. Valuation: 17
Relative Profitability: Rel. Profitability: 44

SI-BONE is a medical device company that pioneered minimally invasive surgery of the SI joint with the iFuse Implant System. Studies have shown that the SI joint can be a ...

Highlights
The EPS rose by 39% YoY and by 11% QoQ
SI-BONE's net income has increased by 37% YoY and by 12% QoQ
SI-BONE's debt has increased by 17% from the previous quarter and by 16% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://si-bone.com
Peers: EQT

Key stats

What are the main financial stats of SIBN

SIBN stock price

How has the SI-BONE stock price performed over time
Intraday
6.9%
1 week
3.26%
1 month
11.46%
1 year
-19.52%
YTD
-24.54%
QTD
17.81%

Financial performance

How have SI-BONE's revenue and profit performed over time
Revenue
$206.22M
Gross profit
$164.13M
Operating income
-$19.94M
Net income
-$16.7M
Gross margin
79.6%
Net margin
-8.1%
SI-BONE's net margin has increased by 46% YoY and by 14% from the previous quarter
The company's operating margin rose by 44% YoY and by 13% QoQ
SI-BONE's net income has increased by 37% YoY and by 12% QoQ
The operating income is up by 35% year-on-year and by 11% since the previous quarter

Price vs fundamentals

How does SIBN's price correlate with its fundamentals

Growth

What is SI-BONE's growth rate over time

Valuation

What is SI-BONE stock price valuation
P/E
N/A
P/B
3.67
P/S
3.17
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.25
The EPS rose by 39% YoY and by 11% QoQ
SIBN's P/B is 27% below its 5-year quarterly average of 4.7 and 16% below its last 4 quarters average of 4.1
The equity rose by 7% YoY
The P/S is 47% less than the 5-year quarterly average of 5.6 and 18% less than the last 4 quarters average of 3.6
The company's revenue rose by 17% YoY and by 2.6% QoQ

Efficiency

How efficient is SI-BONE business performance
The ROS rose by 48% YoY and by 15% QoQ
The ROIC has grown by 42% YoY and by 17% from the previous quarter
The ROE has grown by 40% YoY and by 13% from the previous quarter
SI-BONE's ROA has increased by 39% YoY and by 12% from the previous quarter

Dividends

What is SIBN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SIBN.

Financial health

How did SI-BONE financials performed over time
The current ratio has grown by 17% year-on-year and by 17% since the previous quarter
SI-BONE's quick ratio has increased by 16% QoQ and by 14% YoY
SI-BONE's debt is 76% less than its equity
SI-BONE's debt has increased by 17% from the previous quarter and by 16% YoY
The debt to equity is up by 14% since the previous quarter and by 9% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.